Zentalis Pharmaceuticals Llc

Zentalis Pharmaceuticals Llc (ZNTL) SEC filings

Zentalis Pharmaceuticals Llc (ZNTL) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M. The ZNTL filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Zentalis Pharmaceuticals Llc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

1

8-K

0

Form 4

Recent filings

8-K7.018.01

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all ZNTL filings.

Frequently asked questions

What did ZNTL just say?

ZNTL cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are ZNTL SEC filings?

1 cached filing is on this page. EDGAR remains the official archive (CIK 0001725160).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.